Nicholas Price

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou et al. · Cell · 2022 · 1K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Clark D Russell, Cameron J Fairfield, Thomas M Drake et al. · The Lancet Microbe · 2021 · 334 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +17

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins et al. · Science Immunology · 2021 · 259 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty et al. · The Lancet Respiratory Medicine · 2021 · 196 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Antimicrobial stewardship – can we afford to do without it?

Anna Aryee, Nicholas Price · British Journal of Clinical Pharmacology · 2014 · 126 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +14